After Apple: Tech's Takeover of Healthcare Officially Begins

By Dave Williamson and Michael Douglass – Sep 10, 2014 at 8:21PM

Ebola is spreading, new diabetes and obesity drugs, and Apple and Google move into healthcare, because this is where the money is.

In this edition of Where The Money Is, analysts David Williamson and Michael Douglass give their take on the week's biggest health care headlines.

This episode dissects Apple's (Nasdaq: AAPL) huge presentation yesterday, giving health care investors everything they need to know about how iPhone 6, Apple Watch, and the new IOS 8 HealthKit could take the sector by storm.

Other highlights include a massive deal between Google (Nasdaq: GOOG) Calico venture and big pharma Abbvie; a much needed win for a new Eli Lilly diabetes drug; a potential new weight loss drug from Novo Nordisk, and an important update regarding the alarming Ebola epidemic in Liberia.

David Williamson owns shares of AbbVie., Apple, and Google (C shares). Michael Douglass owns shares of Apple. The Motley Fool recommends Apple and Google (C shares). The Motley Fool owns shares of Apple and Google (C shares). We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Intuitive Surgical (ISRG) Q1 2024 Earnings Call Transcript

Why Ultra-High-Yield Dividend Stock Medical Properties Trust Is Skyrocketing This Week

Medtronic Stock: Buy, Sell, or Hold?

Does This Acquisition Make Vertex Pharmaceuticals Stock a Buy?

2 Growth Stocks That Turned $10,000 Into More Than $100,000 in Just 10 Years

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services

Related Articles

Premium Investing Services